Genvoya and Lipodystrophy acquired - a phase IV clinical study of FDA data

Summary:

Lipodystrophy acquired is reported as a side effect among people who take Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Truvada, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Lipodystrophy acquired when taking Genvoya. It is created by eHealthMe based on reports of 13,480 people who have side effects when taking Genvoya from the FDA, and is updated regularly.

What is Genvoya?

Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.

What is Lipodystrophy acquired?

Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired) is found to be associated with 174 drugs and 238 conditions by eHealthMe. Check the latest studies of Lipodystrophy acquired.

On Jul, 06, 2026

13,480 people reported to have side effects when taking Genvoya.
Among them, 22 people (0.16%) have Lipodystrophy acquired.

Could Genvoya cause Lipodystrophy acquired?

Among these 22 people:

How long have people been on Genvoya when they have Lipodystrophy acquired? *

What is the gender of people who have Lipodystrophy acquired when taking Genvoya? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Lipodystrophy acquired when taking Genvoya? *

What are other drugs people take besides Genvoya? *

What are other side effects people have besides Lipodystrophy acquired? *

Chronic Kidney Disease: 12 people, 54.55%
Pain: 11 people, 50.00%
Stress And Anxiety: 10 people, 45.45%
Emotional Distress: 10 people, 45.45%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 10 people, 45.45%
Osteopenia (a condition where bone mineral density is lower than normal): 10 people, 45.45%
Muscle Aches (muscle pain): 10 people, 45.45%
Weight Increased: 8 people, 36.36%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 8 people, 36.36%
Multiple Injuries: 5 people, 22.73%

What are the existing conditions these people have? *

High Blood Pressure: 1 person, 4.55%
High Blood Cholesterol: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Genvoya and have Lipodystrophy acquired?

- Check whether Lipodystrophy acquired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Genvoya:

Genvoya (13,538 reports)

Lipodystrophy acquired treatments and more:

Lipodystrophy acquired (5,451 reports)

How severe was Lipodystrophy acquired and when was it recovered:

Lipodystrophy acquired in Genvoya

Expand to all the drugs that have ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate:

Lipodystrophy acquired and drugs with ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (26 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Genvoya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lipodystrophy acquired:

Lipodystrophy acquired (174 drugs)

Browse all the conditions that are associated with Lipodystrophy acquired:

Lipodystrophy acquired (238 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Genvoya) and Genvoya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.